Shaida ta nuna goyon baya ga masu amfani da steroid-Resistant Relapses
A. Ƙaramar Plasma, wadda ake kira "plasmapheresis," ta Cibiyar Nazarin Kasuwancin Amirka (AAN) ta ba da shawarar magance matsaloli mai tsanani a cikin mutane tare da sake dawowa da yaduwar kwayar cutar (RRMS), kamar yadda ake zaton "mai yiwuwa tasiri."
Duk da haka, musayar ƙwayar plasma yana bada shawarar a matsayin magani na biyu don sake dawowa wanda bai amsa zuwa hanyar Solu-Medrol ba - ba maimakon Solu-Medrol ba.
An tabbatar da amincewa daga AAN don maganin sake dawowa a RRMS a cikin Janairu 2011 kuma yana canji ga jagororin daga 1996, inda ake kira hanya ne kawai a matsayin "alƙawari" da "mai yiwuwa amfani."
Ya kamata a lura cewa musayar musayar plasma ba ta da shawarar ta hanyar AAN don kula da ƙwayar sakatare na biyu ko na cigaba mai zurfi.
Me yasa Kasuwancin Kasuwanci na Plasma zai Komawa?
Cin musayar plasma ya kawar da abubuwa masu haɗari da suke rarraba a cikin ruwa (plasma) na jini. A cikin yanayin MS, wannan ƙwayar cuta ce game da gina jiki wanda ke haifar da myelin , kazalika da kwayoyin T da kuma wasu wasu kwayoyin da ba za su iya magance myelin ba.
Ana tsammanin cewa cire waɗannan kwayoyin halitta a yayin sake dawowa zai iya iyakance tsawon lokacin sake dawowa da kuma lalacewa ta hanyar kumburi. Duk da haka, da zarar an cire wadannan kwayoyin cutar ko a ajiye su a cikin wulakanci , musayar ƙwayar plasma ba zai iya cire su ba kuma bazai da wata magunguna ba.
Mene ne Shaida ga Kasuwancin Plasma don RRMS Relapses?
A cikin ƙananan ƙwararrun ƙwararrakin, mutane 22 da RRMS ko wasu cututtuka masu tayar da ƙananan cututtuka (ƙetare myelitis, neuromyelitis optica) wanda ya haifar da bayyanar cututtuka sun haɗa su a cikin nazarin musayar musayar plasma. Dukkan mutane sun kasa yin biyayya da hanyar Solu-Medrol kuma yawancin ci gaba akan EDSS shine 7.5 lokacin da suka fara magani.
Ma'aikata guda tara sun "yi alama" zuwa ingantaccen "gyare-gyare" bayan gyaran plasma. Sau biyar daga cikin waɗannan sun ci gaba da samun ci gaba na tsawon shekaru uku.
A cikin wani karamin rukuni, mutane hudu da RRMS sun sake koma baya da basu amsa Solu-Medrol ba. An ba kowannensu haɗin haɗin plasma 5. Mutum daya "alama" dawowa, mutane 2 sun sake dawowa (ko da yake daya daga cikinsu yana buƙatar a yi magunguna sau biyu), kuma mutum daya yana "maida" maida.
Layin Ƙasa
Idan kuna da ciwo mai tsanani wanda ba'a amsawa ga Solu-Medrol, likitanku na iya bayar da shawarar musayar musayar plasma. Hanyoyin musayar plasma yana da matukar hadari mai kyau wanda ba shi da haɗari kuma baya haifar da rashin tausayi.NOTE: Ana amfani da musayar plasma a cikin mutanen da ke da ƙwayar sclerosis wanda aka gano tare da haɗin gwiwar Tysabri da ke ci gaba da haɓaka mai yawa. Ana amfani dashi akai akai tare da magunguna. (Don ƙarin koyo: Q. Mene ne magani ga PML? Tysabri? )
Don ƙarin bayani game da hanyar musayar ƙwayar plasma, karanta: Exchange Plasma (Plasmapheresis) don MS da sauran cututtukan da ba a cutar ba.
Sources:
Cortese I, Chaudhry V, Don haka YT, Cantor F, Cornblath DR, Rae-Grant A. Tabbacin jagorancin shahadar: Plasmapheresis a cikin cututtukan neurologic: Rahoton Cibiyar Nazarin Harkokin Kiwon Lafiyar Harkokin Kimiyya da Cibiyar Harkokin Kasafin Cibiyar Nazari ta Amirka. Ma'anar ilimin halitta. 2011 Janairu 18, 76 (3): 294-300.
Habek M, Barun B, Tsarin Z, Brinar VV. Jiyya na sake dawowa ba tare da amsa ba tare da musayar ƙwayar plasma a cikin ƙananan sclerosis. Gidan Wuta Apan. 2010 Jun; 14 (3): 298-302.
Lehmann HC, Hartung HP, Hetzel GR, Stuve O, Kieseier BC. Exchange Plasma a Cutar Neuroimmunological, Sashe na 1: Halitta da Jiyya na Ciwon Kwayoyin Kwayoyin Flammatory Tsarin Kwayoyin cuta. Arch Neurol. 2006; 63: 930-935.
Weinshenker BG, O'Brien PC, Petterson TM, et al. Wani gwajin gwagwarmaya na musayar ƙwayar plasma a cikin mummunar tsarin jinƙai mai cike da cutar ƙaddarawa. Ann Neurol. 1999; 46: 878-886.